Oxygen-Based Nanocarriers to Modulate Tumor Hypoxia for Ameliorated Anti-Tumor Therapy: Fabrications, Properties, and Future Directions

Over the past five years, oxygen-based nanocarriers (NCs) to boost anti-tumor therapy attracted tremendous attention from basic research and clinical practice. Indeed, tumor hypoxia, caused by elevated proliferative activity and dysfunctional vasculature, is directly responsible for the less effecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xianqiang, Wu, Yue, Zhang, Rui, Bai, Wei, Ye, Tiantian, Wang, Shujun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281198/
https://www.ncbi.nlm.nih.gov/pubmed/34277702
http://dx.doi.org/10.3389/fmolb.2021.683519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281198/
https://www.ncbi.nlm.nih.gov/pubmed/34277702
http://dx.doi.org/10.3389/fmolb.2021.683519

Ejemplares similares